| dc.contributor.author | Robinson Mark | en_US |
| dc.contributor.author | Trudgett A | en_US |
| dc.contributor.author | Fairweather I | en_US |
| dc.contributor.author | Mcferran Neil | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2011-02-07T06:29:09Z | |
| dc.date.available | 2011-02-07T06:29:09Z | |
| dc.date.issued | 2002 | en_US |
| dc.identifier | 2009005087 | en_US |
| dc.identifier.citation | Robinson Mark et al. 2002, 'Benzimidazole binding to Haemonchus contortus tubulin: a question of structure.', Trends in Parasitology, Elsevier Inc, Oxford, UK | en_US |
| dc.identifier.issn | 1471-4922 | en_US |
| dc.identifier.other | C4 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/14176 | |
| dc.description.abstract | The September 2001 issue of Trends in Parasitology had a review entitled `Genetic variability following selection of Haemonchus contortus with anthelmintics¿, by Roger K. Prichard [1]. This included a diagrammatic representation of the proposed benzimidazole (BZM) binding to H. contortus tubulin, presumably based on the electron diffraction structure of porcine tubulin ?-chain [2], although this was not stated. It was suggested that BZM dock with the tubulin molecule within a site formed by four residues on the tubulin ?-chain (Ser166, Phe167, Phe200 and Cys201). We concur that these four ?-tubulin residues cluster together in the published model of the three-dimensional conformation of the protein; however, using this structure, we find the proposed BZM docking to be questionable on the following grounds. | en_US |
| dc.language | en_US | |
| dc.publisher | Elsevier Inc | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1016/S1471-4922(01)02225-5 | en_US |
| dc.title | Benzimidazole binding to Haemonchus contortus tubulin: a question of structure. | en_US |
| dc.parent | Trends in Parasitology | en_US |
| dc.journal.volume | 18 | en_US |
| dc.journal.number | 4 | en_US |
| dc.publocation | Oxford, UK | en_US |
| dc.identifier.startpage | 153 | en_US |
| dc.identifier.endpage | 154 | en_US |
| dc.cauo.name | SCI.Institute for Biotechnology of Infectious Diseases | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 060500 | en_US |
| dc.personcode | 100777;0000033423;0000033422;0000062058 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Microbiology | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | en_US | |
| dc.description.keywords | en_US | |
| dc.staffid | Queen's University Belfast | en_US |